Dr. Salahadin Abdi, M.D.
Claim this profileM D Anderson Cancer Center
Studies Peripheral Neuropathy
Studies Nerve Damage
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Salahadin Abdi, M.D. is currently running
Tetrodotoxin
for Chemotherapy-Induced Neuropathic Pain
To be eligible for the trial, subjects must have ongoing moderate to severe neuropathic pain related to a prior course of platinum and/or taxane chemotherapy and have no clinical evidence of actively progressive disease. The trial period will comprise a Screening period (up to 35 Days), randomization and a 4-day treatment period, followed by a 12-week follow up period (12 weeks total after initial treatment), and an End-of-Trial/Follow-up visit which will occur at Week 13. This is a study to research the effects of the study drug on neuropathic pain compared placebo.
Recruiting0 awards Phase 211 criteria
Scrambler Therapy
for Peripheral Neuropathy
This trial is testing Scrambler Therapy, which uses small electrical currents to reduce pain, on adolescents and young adults with cancer who have painful nerve damage from chemotherapy. The therapy works by interfering with pain messages sent to the brain, making the pain feel less intense. Scrambler therapy is a noninvasive treatment for chronic neuropathic and cancer pain that uses synthetic 'non-pain' information transmitted by C fiber surface receptors.
Recruiting1 award N/A
More about Salahadin Abdi, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Salahadin Abdi, M.D. has experience with
- Scrambler Therapy
- Single Cycle Tetrodotoxin
Breakdown of trials Salahadin Abdi, M.D. has run
Peripheral Neuropathy
Nerve Damage
Peripheral Neuropathic Pain
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Salahadin Abdi, M.D. specialize in?
Salahadin Abdi, M.D. focuses on Peripheral Neuropathy and Nerve Damage. In particular, much of their work with Peripheral Neuropathy has involved treating patients, or patients who are undergoing treatment.
Is Salahadin Abdi, M.D. currently recruiting for clinical trials?
Yes, Salahadin Abdi, M.D. is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Salahadin Abdi, M.D. has studied deeply?
Yes, Salahadin Abdi, M.D. has studied treatments such as Scrambler Therapy, Single Cycle Tetrodotoxin.
What is the best way to schedule an appointment with Salahadin Abdi, M.D.?
Apply for one of the trials that Salahadin Abdi, M.D. is conducting.
What is the office address of Salahadin Abdi, M.D.?
The office of Salahadin Abdi, M.D. is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.